Success Metrics

Clinical Success Rate
86.7%

Based on 52 completed trials

Completion Rate
87%(52/60)
Active Trials
41(29%)
Results Posted
19%(10 trials)
Terminated
8(6%)

Phase Distribution

Ph phase_4
5
4%
Ph phase_1
3
2%
Ph early_phase_1
1
1%
Ph not_applicable
40
29%
Ph phase_2
3
2%

Phase Distribution

4

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution52 total trials
Early Phase 1First-in-human
1(1.9%)
Phase 1Safety & dosage
3(5.8%)
Phase 2Efficacy & side effects
3(5.8%)
Phase 4Post-market surveillance
5(9.6%)
N/ANon-phased studies
40(76.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.9%

52 of 62 finished

Non-Completion Rate

16.1%

10 ended early

Currently Active

41

trials recruiting

Total Trials

140

all time

Status Distribution
Active(54)
Completed(52)
Terminated(10)
Other(24)

Detailed Status

Completed52
Recruiting32
unknown24
Not yet recruiting12
Active, not recruiting9
Terminated8

Development Timeline

Analytics

Development Status

Total Trials
140
Active
41
Success Rate
86.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.9%)
Phase 13 (5.8%)
Phase 23 (5.8%)
Phase 45 (9.6%)
N/A40 (76.9%)

Trials by Status

unknown2417%
not_yet_recruiting129%
active_not_recruiting96%
recruiting3223%
terminated86%
withdrawn21%
enrolling_by_invitation11%
completed5237%

Recent Activity

Clinical Trials (140)

Showing 20 of 140 trialsScroll for more
NCT04165798

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

Recruiting
NCT07232550

Biomarkers and Respiratory Omics as New CHildren Opportunities - Study of Clinical Outcomes and Predictivity Evaluation

Recruiting
NCT07455136

A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury

Recruiting
NCT07436637Not Applicable

Guardant Shield Colorectal Cancer Screening

Recruiting
NCT07063719Not Applicable

Identification of Cellular Biomarkers of Rare Eye Diseases in Adults

Recruiting
NCT03851133

Florida Pancreas Collaborative Next Generation Biobank

Active Not Recruiting
NCT07665255

CIRP and Cathepsin B in Neuroinflammation After Intracerebral Hemorrhage

Not Yet Recruiting
NCT07650565Not Applicable

Tissue Modeling in Systemic Sclerosis Using Induced Pluripotent Stem Cells (iPSCs)

Not Yet Recruiting
NCT07499739Phase 4

Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the Congo

Active Not Recruiting
NCT07636213

BRIDGE-US: Bridging Readiness in Deployed Neurotrauma Gaps for Excellence

Not Yet Recruiting
NCT05307809Not Applicable

Cytokine Expression in Psoriasis Patients With and Without Joint Involvement

Recruiting
NCT05687188

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

Recruiting
NCT05487248Not Applicable

A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients

Active Not Recruiting
NCT07499921Not Applicable

Clinical and BIOgical Analyses of RECtal Tumors

Not Yet Recruiting
NCT03595813Not Applicable

Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy

Completed
NCT07516392Not Applicable

Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma

Not Yet Recruiting
NCT07054346Phase 1

Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617

Recruiting
NCT06695494

Enabling Genomic Testing in Cancer of Unknown Primary

Recruiting
NCT07201636Not Applicable

Natural History Study for Patients With Nemaline Myopathy in Belgium

Not Yet Recruiting
NCT05306288

CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung

Active Not Recruiting

Drug Details

Intervention Type
PROCEDURE
Total Trials
140